학술논문

Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta(42) in patients with Alzheimer's disease
Document Type
Journal
Source
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS; MAR 2003, 10 1, p1-p6, 6p.
Subject
Language
English
ISSN
13506129